Guntram Schernthaner

基本信息

Career Trajectory

Bio

I am clinical diabetologist with a special interest in prevention and treatment of vascular disease, new therapeutic strategies for type 2 diabetes, metabolic surgery and immunintervention of type 1 diabetes

Research Interests

Papers共 161 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Metformin and the heart: Update on mechanisms of cardiovascular protection with special reference to comorbid type 2 diabetes and heart failure

Guntram Schernthaner,Kerstin Brand,Clifford J Bailey

Metabolism（2022）

Cited33Views0WOSBibtex

Decrease of Dipeptidyl Peptidase 4 Activity is Associated with Weight Loss after Bariatric Surgery

Klinik Landstraße, Karl Landsteiner Institute for Obesity and Metabolic Disorders,Schernthaner Guntram,Schernthaner Gerit-Holger

Obesity Surgery（2021）

Cited4Views0WOSBibtex

Frequency of Hypoglycaemia after Different Bariatric Surgical Procedures

Johanna Maria Brix,Hans-Peter Kopp,Florian Hoellerl,Gerit Holger Schernthaner,Bernhard Ludvik,Guntram Schernthaner

Obesity Facts（2019）

Cited27Views0WOSBibtex

Diabetische Nierenerkrankung (update 2019)

Harald Sourij,Roland Edlinger,Friedrich C. Prischl,Martin Auinger,Susanne Kaser,Sabine Horn,Bernhard Paulweber,Alexandra Kautzky-Willer,Marcus Säemann,Rudolf Prager,Martin Clodi,Guntram Schernthaner,Gert Mayer,Rainer Oberbauer,Alexander R. Rosenkranz

Wiener klinische Wochenschrift（2019）

Cited2Views0Bibtex

Albuminuria in Patients with Morbid Obesity and the Effect of Weight Loss Following Bariatric Surgery

Johanna Maria Brix,Carsten Thilo Herz,Hans Peter Kopp,Astrid Feder,Eva-Christina Krzizek,Christoph Sperker,Gerit-Holger Schernthaner,Guntram Schernthaner,Bernhard Ludvik

Obesity Surgery（2019）

Cited7Views0WOSBibtex

[Individualising antihypertensive therapy in patients with diabetes. A guideline by the Austrian Diabetes Association (Update 2019)]

Guntram Schernthaner,Christoph H Saely,Gerit-Holger Schernthaner,Bruno Watschinger,Heinz Drexel

WIENER KLINISCHE WOCHENSCHRIFT（2019）

Cited4Views0WOSBibtex

CARMELINA: an Important Piece of the DPP-4 Inhibitor CVOT Puzzle

Guntram Schernthaner,Christoph Wanner,Dubravka Jurisic-Erzen,Cristian Guja,Janusz Gumprecht,Iwona R. Jarek-Martynowa,Avraham Karasik,Nebojsa Lalic,Boris N. Mankovsky,Martin Prazny,Tsvetalina Tankova,Anat Tsur,Thomas C. Wascher,Istvan Wittmann

Diabetes Research and Clinical Practice（2019）

Cited7Views0WOSBibtex

Slope of Change in HbA1c from Baseline with Empagliflozin Compared with Sitagliptin or Glimepiride in Patients with Type 2 Diabetes

Ralph A. DeFronzo,Ele Ferrannini,Guntram Schernthaner,Stefan Hantel,Ulrich Elsasser,Christopher Lee,Thomas Hach,Soren S. Lund

Endocrinology Diabetes & Metabolism（2018）

Cited12Views0WOSBibtex

Prevalence of Micronutrient Deficiency in Patients with Morbid Obesity Before Bariatric Surgery

Eva-Christina Krzizek,Johanna Maria Brix,Carsten Thilo Herz,Hans Peter Kopp,Gerit-Holger Schernthaner,Guntram Schernthaner,Bernhard Ludvik

Obesity Surgery（2018）

Cited76Views0WOSBibtex

Advances in the Management of Cardiovascular Risk for Patients with Type 2 Diabetes: Perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes

Guntram Schernthaner,Sarah Jarvis,Chaim Lotan,Martin Prazny,Christoph Wanner,Thomas C. Wascher

Therapeutics and Clinical Risk Management（2017）

Cited8Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Managing Director

Papers共 161 篇Author StatisticsCo-AuthorSimilar Experts